Tag Archive for: Collaboration

Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie

/in

March 1, 2022 Deal value of US$ 1 billion with US$ 130 million upfront Novo Holdings co-created Syndesi Therapeutics in partnership with UCB Pharma and co-led the Series A financing Syndesi’s lead program SDI-118 to be accelerated by AbbVie to the benefit of patients suffering from cognitive impairment associated with a range of neurodegenerative and […]

Read more

Genmab and Synaffix Enter into License Agreement for ADC Technology

/in

Synaffix to provide access to proprietary antibody-drug conjugate (ADC) technologies Genmab secures rights for conducting research on ADCs against multiple drug targets with options for exclusive worldwide development and commercialization of resulting therapies Synaffix to receive an upfront payment of USD $4.5 million with a total deal value of up to USD $415 million plus […]

Read more
© Optimum Strategic Communications.